SCHEMBL4452813

SCHEMBL4452813

CCN(CC)CCCC(C)Nc1cc(O)c2nc(C)cc(C)c2c1

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.45
HSP90AB1 P08238 1/20 0.45
MAPT P10636 1/20 0.45
RAC1 P63000 1/20 0.45
CACNA2D1 P54289 9/20 0.44
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CCR4 P51679 1/20 0.41
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4452814 0.73 L3MBTL1 (0.35) CCR4
SCHEMBL3389936 0.69 RAC1 (0.79) MAPTRAC1CACNA2D1CCR4
SCHEMBL23883133 0.66 CACNA2D1 (0.77) CACNA2D1CCR4
SCHEMBL1613020 0.64 CHRM2 (0.71) MAPTCACNA2D1TMEM97SIGMAR1CYP2D6
SCHEMBL3392632 0.64 RAC1 (0.58) MAPTRAC1CACNA2D1TMEM97SIGMAR1
SCHEMBL14568564 0.63 CCR4 (0.48) HSP90AA1HSP90AB1CACNA2D1CCR4
SCHEMBL4452049 0.63 CACNA2D1 (0.53) HSP90AA1HSP90AB1CACNA2D1CCR4
SCHEMBL14424686 0.62 NSD2 (0.54) HSP90AA1HSP90AB1TMEM97SIGMAR1CYP2D6
SCHEMBL17829618 0.62 CCR4 (0.53) CACNA2D1CCR4
SCHEMBL3392823 0.62 MAPT (0.47) HSP90AA1HSP90AB1MAPTRAC1CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009140215-A2 METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS GERAGHTY, ERIN (US) 2009-11-19 WO claimed
WO-2009140215-A2 METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS GERAGHTY, ERIN (US) 2009-11-19 WO disclosed